{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:22:29Z","timestamp":1783700549810,"version":"3.55.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:00:00Z","timestamp":1491955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0175283","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T14:44:59Z","timestamp":1492008299000},"page":"e0175283","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and safety of aspirin in patients with peripheral vascular disease: An updated systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1371","volume":"12","author":[{"given":"Ahmed N.","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecil","family":"Rambarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Mahtta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3545-370X","authenticated-orcid":true,"given":"Anthony A.","family":"Bavry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"FG Fowkes","year":"2013","journal-title":"Lancet"},{"key":"ref2","article-title":"2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","author":"MD Gerhard-Herman","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2 Suppl","key":"ref3","doi-asserted-by":"crossref","first-page":"e669S","DOI":"10.1378\/chest.11-2307","article-title":"Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"P Alonso-Coello","year":"2012","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2014I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/bmj.296.6618.320","article-title":"Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration","volume":"296","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.amjmed.2014.09.028","article-title":"Impact of aspirin according to type of stable coronary artery disease: insights from a large international cohort","volume":"128","author":"AA Bavry","year":"2015","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"JS Berger","year":"2009","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.0007-1323.2001.01774.x","article-title":"Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease","volume":"88","author":"P Robless","year":"2001","journal-title":"Br J Surg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"C Baigent","year":"2009","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"FG Fowkes","year":"2010","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.116.025880","article-title":"Ticagrelor compared with clopidogrel in patients with prior lower extremity revascularization for peripheral artery disease","volume":"135","author":"WS Jones","year":"2017","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"JP Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"D Atkins","year":"2004","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"VN Nyaga","year":"2014","journal-title":"Arch Public Health"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1582-4934.2008.00631.x","article-title":"Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate","volume":"13","author":"M Arbyn","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"S Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"J Belch","year":"2008","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","article-title":"Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial","volume":"261","author":"M Catalano","year":"2007","journal-title":"J Intern Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(85)91144-4","article-title":"Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial","volume":"1","author":"H Hess","year":"1985","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF01658734","article-title":"The effect of acetylsalicylic acid on the outcome after lower limb arterial surgery with special reference to cigarette smoking","volume":"15","author":"R Lassila","year":"1991","journal-title":"World J Surg"},{"key":"ref25","first-page":"1016","article-title":"Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency","volume":"92","author":"RM Green","year":"1982","journal-title":"Surgery"},{"key":"ref26","first-page":"141","article-title":"Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery","volume":"22","author":"PT Harajola","year":"1981","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"ref27","first-page":"128","article-title":"The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis","volume":"31","author":"K Roztocil","year":"1989","journal-title":"Cor Vasa"},{"key":"ref28","first-page":"1157","article-title":"Use of acetylsalicylic acid in the prevention of re-occlusion following revascularization interventions. Results of a double-blind long term study","volume":"28","author":"U Ehresmann","year":"1977","journal-title":"Med Welt"},{"key":"ref29","unstructured":"Hess H and Keil-Kuri E. Theoretische grundlagen der prophylaxe obliterierender arteriopathien mit aggregationshemmern und ergebnisse einer langzeitstudie mit ASS (Colfarit). In: Marx R, Breddin HK, eds. Proceedings of Colfarit Symposium III. K\u00f6ln, Germany: Bayer; 1975: 80\u201387."},{"key":"ref30","first-page":"68","article-title":"Thrombosen, Embolien und Aggregationshemmer in der Chirurgie","author":"F Zekert","year":"1975"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"FG Fowkes","year":"2008","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1001\/jama.297.18.2018","article-title":"Aspirin dose for the prevention of cardiovascular disease: a systematic review","volume":"297","author":"CL Campbell","year":"2007","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"164","author":"K Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jacc.2004.11.041","article-title":"Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis","volume":"45","author":"E Ferrari","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0175283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:14:25Z","timestamp":1540340065000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0175283"}},"subtitle":[],"editor":[{"given":"Lise Lotte","family":"Gluud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0175283","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]}}}